As oligodendrocyte loss and myelin dysfunction has recently been emphasized in neurodegenerative diseases, including ALS, it is essential to investigate the relationship between SVAs and MBP differential expressions [50,51]. This evidence concerns the gene MBP and amyotrophic lateral sclerosis.